[ad_1] SAN DIEGO, Sept. 5, 2023 /PRNewswire/ — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that its Board of Directors has appointed…
Tag: Illuminas
FTC Rejects Illumina’s $7 Billion Deal for Cancer-Test Developer Grail
[ad_1] The agency said the combination would hurt competition for cancer-detection tests while raising prices. [ad_2] Source link